...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith News

It sure would be nice if something....anything....happened here that was conclusive.  Things seem to just kind of hang in limbo.

 

Share
New Message
Please login to post a reply